Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preservative-free Low-dose Hyaluronic Acid in Dry Eye Disease
NCT03888183Phase 4Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Apr 2019
- Primary completion
- Jan 2020
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hyaluronic acid sodium salt in dry eye disease (DED) (2 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Central Tear Meniscus Height at 4 weeks. Status: unknown.
02
Drugs
hyaluronic acid sodium salt
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT03888183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03888183.